4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with oxidopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beitz, AJ; Choi, SM; Han, HJ; Jeong, TO; Kim, HW; Kwon, YB; Lee, HJ; Lee, JH; Roh, DH; Ryu, YH; Yoon, SY | 1 |
1 other study(ies) available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and oxidopamine
| Article | Year |
|---|---|
The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Atropine; Autonomic Fibers, Preganglionic; Bee Venoms; Catecholamines; Cell Count; Choline O-Acetyltransferase; Disease Models, Animal; Drug Interactions; Exudates and Transudates; Hexamethonium; Immunohistochemistry; Inflammation; Leukocytes; Male; Mice; Mice, Inbred ICR; Muscarinic Antagonists; Neurons; Nicotinic Antagonists; Oncogene Proteins v-fos; Oxidopamine; Piperidines; Pirenzepine; Receptor, Muscarinic M2; Spinal Cord; Sympathectomy, Chemical | 2005 |